MapMyGenome launches pharmacogenomics solution covering more than 165 drugs

MapMyGenome, a preventive genomics company, launched its pharmacogenomics solution MedicaMap on December 4, 2022, which analyses an individual's response to medicines based on genetic makeup. Currently MedicaMap analyses 165 plus US-FDA-approved...

Pfizer to invest more than $2.5 bln to expand European manufacturing

Pfizer Inc is investing more than $2.5 billion at its drug-making plants in Belgium and Ireland, gearing up to launch new products it hopes can replace lost revenue as patents expire and COVID-19 vaccine sales decline...

Importance of having a separate ministry for Pharma sector

How important is it to have a separate ministry for pharma sector and what are the various measures the industry should take in order to address the various challenges the industry is facing today.

Citeline supports Informa Markets' 4th Edition of CPhI & PMEC India Expo

Citeline partnered with CPHI and Informa Markets as a Knowledge Partner for the Pre-Connect Congress and CPhl CEO Round Table during the 2022 edition of CPhI & PMEC India. The online conference of CPhI & PMEC India commenced on 15th November and...

Alembic Pharmaceuticals receives USFDA Approval for Diclofenac Sodium Topical Solution USP

Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA), Diclofenac Sodium Topical Solution USP, 2% w/w....

Akums enters into a joint association with Leiutis and Biophore for introducing first-of-its-kind therapeutics

To leverage the research expertise and combined manufacturing capacities to introduce first-of-its-kind products in India, Akums Drugs & Pharmaceuticals Ltd, has partnered with Leiutis Pharmaceuticals LLP and Biophore India Pharmaceuticals for ...

Horizon Therapeutics fields buyout interest from Amgen, J&J and Sanofi

Horizon Therapeutics Plc said on Tuesday its board was engaged in highly preliminary discussions with three pharmaceutical giants for potential takeover offers, sending its shares surging 31 per cent in extended trading...

Biocon Biologics completes acquisition of Viatris' global biosimilars biz

Biocon Biologics completes acquisition of Viatris' global biosimilars bizNew Delhi, Biocon on Tuesday said its unit Biocon Biologics has completed the multi-billion dollar acquisition of the global biosimilars business of its partner Viatris Inc....

Lupin's Brazilian Subsidiary, MedQuimica Acquires Rights to Nine Brands from Bausch Health

Global pharma major, Lupin Limited (Lupin) announced today that its wholly owned subsidiary in Brazil, MedQuímica Indústria Farmacêutica (MedQuímica), has signed a definitive agreement to acquire all rights to nine medicines from BL...

HOSMAT deploys robotic surgery unit to achieve accurate and precision surgical interventions

HOSMAT Hospital, the dedicated orthopaedic care provider has now installed the 3rd generation CUVIS robotic surgery unit, at its facility in Bengaluru. This is the 2nd medical centre in Karnataka to have this latest automated robotic system after...

© 2025 India Pharma Outlook. All Rights Reserved.